Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Discovery of therapeutic antibodies
- Discovery of monoclonal antibodies
- Rat Campath-1: a therapeutic antibody
- IgG structure and genes
- IgG antibody
- Mouse-human chimaeric antibodies
- Antibody variable regions
- Humanized antibodies
- Packing of CDRs and FRs
- Auto-correction with antigen?
- Campath-1H: treatment of NHL
- Campath
- Number of mAbs entering clinical studies by year
- Immunogenicity of engineered antibodies
- Avastin and Herceptin
- FDA-approved therapeutic antibodies
- Human antibodies
- The immune strategy
- Generation of diversity: VH repertoires
- Combinatorial VH x VL repertoires
- Phage display of antibody scFv fragment
- Selecting antibodies by phage display
- Imaging with anti-EDB
- Humanising by guided selection
- Humira
- Other human antibodies
- Antibody single domain
- Aggregation of proteins
- Human\camel single domains
- Heat-cool selection of VH by protein A
- Properties of dAbs from CDR-only repertoire
- Heat-cool selection by infectivity
- Single antibody domains: a versatile platform
Topics Covered
- Therapeutic antibodies
- Monoclonal antibodies
- Rat Campath-1
- IgG structure and genes
- IgG antibody
- Mouse-human chimeric antibodies
- Humanized antibodies
- Campath-1H
- B-cell chronic lymphocytic leukemia (B-CLL)
- Multiple sclerosis
- Immunogenicity of engineered antibodies
- Avastin and Herceptin
- The immune strategy
- Generation of diversity
- Humira
- Human therapeutic antibodies
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Winter, G. (2007, October 1). Antibodies by protein engineering [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/WLDN2642.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Sir Gregory Winter has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.